최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Inflammation, v.35 no.4, 2012년, pp.1392 - 1401
Xie, Xiao-hong , Zang, Na , Li, Si-min , Wang, Li-jia , Deng, Yu , He, Yun , Yang, Xi-qiang , Liu, En-mei
Respiratory syncytial virus (RSV) is the most common pathogen responsible for lower respiratory diseases in children. So far, there is no effective treatment or preventative vaccine available for RSV infection, although ribavirin and dexamethasone are commonly prescribed. Resveratrol has been shown ...
Journal of Virology Z Jiang 72 3 2496 1998 10.1128/JVI.72.3.2496-2499.1998 Jiang, Z., M. Kunimoto, and J.A. Patel. 1998. Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus. Journal of Virology 72(3): 2496-2499.
10.1152/ajplung.1996.271.2.L201 Mastronarde, J.G., M.M. Monick, T.J. Gross, and G.W. Hunninghake. 1996. Amiloride inhibits cytokine production in epithelium infected with respiratory syncytial virus. American Journal of Physiology (2 Pt 1):L201-L207.
Lancet G Roosevelt 348 9023 292 1996 10.1016/S0140-6736(96)02285-4 Roosevelt, G., K. Sheehan, J. Grupp-Phelan, R.R. Tanz, and R. Listernick. 1996. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 348(9023): 292-295.
Journal of Infectious Diseases SC Buckingham 185 9 1222 2002 10.1086/340024 Buckingham, S.C., H.S. Jafri, and A.J. Bush. 2002. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. Journal of Infectious Diseases 185(9): 1222-1228.
Thorax JB Woensel van 58 5 383 2003 10.1136/thorax.58.5.383 van Woensel, J.B., W.M. van Aalderen, W. de Weerd, N.J. Jansen, J.P. van Gestel, D.G. Markhorst, et al. 2003. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 58(5): 383-387.
American Journal of Respiratory and Critical Care Medice AM Guerguerian 160 3 829 1999 10.1164/ajrccm.160.3.9810013 Guerguerian, A.M., M. Gauthier, M.H. Lebel, C.A. Farrell, and J. Lacroix. 1999. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medice 160(3): 829-834.
Antiviral Research JJ Docherty 43 3 145 1999 10.1016/S0166-3542(99)00042-X Docherty, J.J., M.M. Fu, B.S. Stiffler, R.J. Limperos, C.M. Pokabla, and A.L. DeLucia. 1999. Resveratrol inhibition of herpes simplex virus replication. Antiviral Research 43(3): 145-155.
Journal of Infectious Diseases AT Palamara 191 10 1719 2005 10.1086/429694 Palamara, A.T., L. Nencioni, K. Aquilano, G. De Chiara, L. Hernandez, F. Cozzolino, et al. 2005. Inhibition of influenza A virus replication by resveratrol. Journal of Infectious Diseases 191(10): 1719-1729.
Antiviral Research DL Evers 63 2 85 2004 10.1016/j.antiviral.2004.03.002 Evers, D.L., X. Wang, S.M. Huong, D.Y. Huang, and E.S. Huang. 2004. 3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Research 63(2): 85-95.
Antiviral Research JJ Docherty 72 3 171 2006 10.1016/j.antiviral.2006.07.004 Docherty, J.J., T.J. Sweet, E. Bailey, S.A. Faith, and T. Booth. 2006. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Research 72(3): 171-177.
Journal of Immunology HS Youn 175 5 3339 2005 10.4049/jimmunol.175.5.3339 Youn, H.S., J.Y. Lee, K.A. Fitzgerald, H.A. Young, S. Akira, and D.H. Hwang. 2005. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. Journal of Immunology 175(5): 3339-3346.
Journal of Immunology DJ Groskreutz 176 3 1733 2006 10.4049/jimmunol.176.3.1733 Groskreutz, D.J., M.M. Monick, L.S. Powers, T.O. Yarovinsky, D.C. Look, and G.W. Hunninghake. 2006. Respiratory syncytial virus inducesTLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. Journal of Immunology 176(3): 1733-1740.
Journal of Immunology BD Rudd 176 3 1937 2006 10.4049/jimmunol.176.3.1937 Rudd, B.D., J.J. Smit, R.A. Flavell, L. Alexopoulou, M.A. Schaller, A. Gruber, et al. 2006. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. Journal of Immunology 176(3): 1937-1942.
Journal of Interferon and Cytokine Research JA Majde 20 3 259 2000 10.1089/107999000312397 Majde, J.A. 2000. Viral double-stranded RNA, cytokines, and the flu. Journal of Interferon and Cytokine Research 20(3): 259-272.
Pediatric Research XH Xie 65 2 156 2009 10.1203/PDR.0b013e318191f5c6 Xie, X.H., H.K. Law, L.J. Wang, X. Li, X.Q. Yang, and E.M. Liu. 2009. Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatric Research 65(2): 156-162.
American Journal of Physiology. Lung Cellular and Molecular Physiology LE Donnelly 287 4 774 2004 10.1152/ajplung.00110.2004 Donnelly, L.E., R. Newton, G.E. Kennedy, P.S. Fenwick, R.H. Leung, K. Ito, et al. 2004. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. American Journal of Physiology. Lung Cellular and Molecular Physiology 287(4): 774-783.
American Journal of Physiology. Lung Cellular and Molecular Physiology J Ciencewicki 290 6 L1154 2006 10.1152/ajplung.00318.2005 Ciencewicki, J., L. Brighton, W.D. Wu, M. Madden, and I. Jaspers. 2006. Diesel exhaust enhances virus- and poly(I:C)-induced Toll-like receptor 3 expression and signaling in respiratory epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 290(6): L1154-L1163.
Journal of Membrane Biology T Melkamu 229 2 101 2009 10.1007/s00232-009-9175-3 Melkamu, T., D. Squillace, H. Kita, and S.M. O'Grady. 2009. Regulation of TLR2 expression and function in human airway epithelial cells. Journal of Membrane Biology 229(2): 101-113.
Journal of Biological Chemistry L Guillot 280 7 5571 2005 10.1074/jbc.M410592200 Guillot, L., R. Le Goffic, S. Bloch, N. Escriou, S. Akira, M. Chignard, et al. 2005. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. Journal of Biological Chemistry 280(7): 5571-5580.
PLoS Pathogens R Goffic Le 2 6 e53 2006 10.1371/journal.ppat.0020053 Le Goffic, R., V. Balloy, M. Lagranderie, L. Alexopoulou, N. Escriou, R. Flavell, et al. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathogens 2(6): e53.
Molecular and Cellular Biology TA Libermann 10 5 2327 1990 10.1128/MCB.10.5.2327 Libermann, T.A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular and Cellular Biology 10(5): 2327-2334.
Molecular Immunology ZW Li 41 6-7 701 2004 10.1016/j.molimm.2004.04.012 Li, Z.W., R.C. Rickert, and M. Karin. 2004. Genetic dissection of antigen receptor induced-NF-kappaB activation. Molecular Immunology 41(6-7): 701-714.
Science M Yamamoto 301 5633 640 2003 10.1126/science.1087262 Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301(5633): 640-643.
Journal of Biological Chemistry N Cusson-Hermance 280 44 36560 2005 10.1074/jbc.M506831200 Cusson-Hermance, N., S. Khurana, T.H. Lee, K.A. Fitzgerald, and M.A. Kelliher. 2005. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. Journal of Biological Chemistry 280(44): 36560-36566.
Nature Y Tojima 404 6779 778 2000 10.1038/35008109 Tojima, Y., A. Fujimoto, M. Delhase, et al. 2000. NAK is an IkappaB kinase-activating kinase. Nature 404(6779): 778-782.
Immunity H An 25 6 919 2006 10.1016/j.immuni.2006.10.014 An, H., W. Zhao, J. Hou, Y. Zhang, Y. Xie, Y. Zheng, et al. 2006. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 25(6): 919-928.
American Journal of Physiology SJ Levine 265 4 Pt1 L360 1993 Levine, S.J., P. Larivée, C. Logun, C.W. Angus, and J.H. Shelhamer. 1993. Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. American Journal of Physiology 265(4 Pt1): L360-L368.
Hepatology L Franceschi De 31 4 997 2000 10.1053/he.2000.5789 De Franceschi, L., G. Fattovich, F. Turrini, K. Ayi, C. Brugnara, F. Manzato, et al. 2000. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 31(4): 997-1004.
Journal of Virology N Zang 85 24 13061 2011 10.1128/JVI.05869-11 Zang, N., X. Xie, Y. Deng, S. Wu, L. Wang, C. Peng, et al. 2011. Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. Journal of Virology 85(24): 13061-13068.
Biochemical and Biophysical Research Communications SS Leonard 309 4 1017 2003 10.1016/j.bbrc.2003.08.105 Leonard, S.S., C. Xia, B.H. Jiang, B. Stinefelt, H. Klandorf, and G.K. Harris. 2003. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochemical and Biophysical Research Communications 309(4): 1017-1026.
Nature Reviews. Drug Discovery JA Baur 5 6 493 2006 10.1038/nrd2060 Baur, J.A., and D.A. Sinclair. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews. Drug Discovery 5(6): 493-506.
Diabetes, Obesity & Metabolism C Lu 10 4 347 2008 10.1111/j.1463-1326.2008.00866.x Lu, C., I.F. Bambang, J.S. Armstrong, and M. Whiteman. 2008. Resveratrol blocks high glucose-induced mitochondrial reactive oxygen species production in bovine aortic endothelial cells: role of phase 2 enzyme induction? Diabetes, Obesity & Metabolism 10(4): 347-349.
Journal of Biological Chemistry T Liu 279 4 2461 2004 10.1074/jbc.M307251200 Liu, T., S. Castro, A.R. Brasier, M. Jamaluddin, R.P. Garofalo, and A. Casola. 2004. Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. Journal of Biological Chemistry 279(4): 2461-2469.
American Journal of Respiratory and Critical Care Medicine SM Castro 174 12 1361 2006 10.1164/rccm.200603-319OC Castro, S.M., A. Guerrero-Plata, G. Suarez-Real, P.A. Adegboyega, G.N. Colasurdo, and A.M. Khan. 2006. Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. American Journal of Respiratory and Critical Care Medicine 174(12): 1361-1369.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.